Most participants were white, so more diversity could be important in future trials
If your Current Weight is: Your new weight could be: Average study participant lost 15% *In the STEP 5 trial, participants for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes, patients taking semaglutide (typically in doses of 2.4 mg once weekly) for weight management lost an average of about 15% of their body weight over 68 weeks
Then, it's placed under a deep vacuum, causing the frozen water to turn directly into vapor and leave the vial (a process called sublimation)
Proven Results: Thanks to GLP-1s unique mechanism of action, significant results have already been achieved in diabetes treatment and weight management, making it a trusted and effective tool for your health journey
While DIL is rare, its essential to consider this risk when evaluating whether GLP-1 drugs are the right choice for someone with lupus